We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 142,735 | 07:46:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.54 | 2.2M |
TIDMEVG
RNS Number : 0925B
Evgen Pharma PLC
05 January 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ----------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Evgen Pharma plc the underlying issuer of existing shares to which voting rights are attached: ----------------------------------------------------- ---------------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights --------------------------------------------------------------------------------------------- ------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------------------------- ------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------------------------------- ------------ An event changing the breakdown of voting rights --------------------------------------------------------------------------------------------- ------------ Other (please change in percentage of voting rights ü specify): arising upon a new issue of shares by the issuer ---------------------------------------------------- --------------------------------------- ------------ 3. Full name of person(s) Enterprise Ventures Limited subject to the notification obligation: ----------------------------------------------------- ---------------------------------------------------- 4. Full name of shareholder(s) RisingStars Growth Fund II (if different from 3.): LP ----------------------------------------------------- ---------------------------------------------------- 5. Date of the transaction Total Voting Rights announcement and date on of the issuer dated 2(nd) which the threshold is January 2018 crossed or reached: ----------------------------------------------------- ---------------------------------------------------- 6. Date on which issuer 4(th) January 2017 notified: ----------------------------------------------------- ---------------------------------------------------- 7. Threshold(s) that is/are crossed or reached: 13% ----------------------------------------------------- ---------------------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------------------- --------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights ------------- -------------------------- ---------------- --------------- ------------------------ -------------------- Direct Direct Indirect Direct Indirect ------------- --------- ----------- ------------ --------------- ----------- ----------- --------- --------- GB00BSVYN304 11,950,869 11,950,869 11,950,869 11,950,869 Nil 12.81 Nil ------------- -------------------------- ---------------- --------------- ----------- ----------- --------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument Period may be acquired if the instrument is exercised/ converted. ----------------- ------------------------ ------------------ ------------------------------------- -------------------- None ----------------- ------------------------ ------------------ ------------------------------------- -------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights instrument period refers to --------------- ----------- --------------- -------------- ---------------------------- ------------------------------- None Nominal Delta --------------- ----------- --------------- -------------- ---------------------------- ----------- ------------------ Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------------------- ------------------------------------------------------------- 11,950,869 12.81% ------------------------------------------------------------- ------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ------------------------------------------------------------------------------------------- Proxy Voting: ------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ---------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ---------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ---------------------------- 13. Additional information: ------------------------------------------------------------- ---------------------------- 14. Contact name: Enterprise Ventures Limited ------------------------------------------------------------- ---------------------------- 15. Contact telephone number: 01772 270 570 ------------------------------------------------------------- ----------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGCGDBLSGBGIU
(END) Dow Jones Newswires
January 05, 2018 04:48 ET (09:48 GMT)
1 Year Evgen Pharma Chart |
1 Month Evgen Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions